Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 53

Posts Tagged ‘infection’

Cook Medical and Ambu A/S Announce Collaboration to Address Endoscope-Related Infections

Posted by fidest press agency su lunedì, 20 maggio 2019

Cook Medical and Ambu A/S have agreed on terms to enter into a partnership under which Cook will distribute Ambu’s single-use, disposable duodenoscope in the U.S., following FDA clearance. The scope is currently being developed by Ambu to help address infections caused by cross-contamination.* Since 2015, U.S. regulatory authorities have increased their focus on endoscope cross-contamination, particularly reusable endoscopes for gastrointestinal use.The use of reusable endoscopes can pose a contamination risk to patients because the devices are difficult to reprocess between uses. Alternatively, single-use scopes could have a significant impact on device-related infections and improve hospital workflows because they do not require cleaning or repair.“Our mission is to improve patient care and we were looking for a solution to reduce the risk of infections associated with the use of reusable endoscopes,” said Barry Slowey, vice president of Cook Medical’s Endoscopy business. “Our collaboration with Ambu is based on a shared goal to enhance patient safety.”
“This is a significant milestone towards our vision of a single-use ERCP solution,” said Juan Jose Gonzalez, CEO of Ambu. “Together with Cook Medical we plan to bring single-use endoscopes to patients undergoing ERCP procedures, to reduce the risk of serious cross-contaminations.” No further details about the agreement will be disclosed at this time.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

QIAGEN’s QuantiFERON-TB® Gold Plus Gains Endorsement for Latent Tuberculosis Screening in Immigration

Posted by fidest press agency su giovedì, 15 marzo 2018

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its QuantiFERON-TB® Gold Plus (QFT-Plus), the gold standard in accurate, cost-effective testing for latent tuberculosis (TB) infection, has been endorsed for immigration medical screening by the International Panel Physicians Association (IPPA). IPPA is a not-for-profit physician education group that works with countries that receive immigrants and refugees, including Australia, Canada, New Zealand, the United Kingdom and the United States. IPPA will hold its 2018 Intergovernmental Physician Training Summit from March 12-16 in Kuala Lumpur, Malaysia.
In a statement the IPPA called the modern class of TB tests known as interferon gamma release assays (IGRAs) “essential to the safety and efficacy of screening programs designed for early detection of TB infection.” Panel physicians, who are medically trained, licensed and experienced doctors practicing overseas and appointed by receiving country governments to handle the mandatory pre-departure medical examinations of migrants, will now be required to use IGRAs for TB screening. For the United States, more than 760 overseas panel physicians worldwide are responsible for examinations of more than one-half million migrants a year receiving permanent lawful residence in the U.S.IPPA said it “endorses the use of QFT-Plus, which is an FDA-approved IGRA that has been rigorously studied and validated by independent peer reviewed journals.” QuantiFERON-TB Gold Plus, the fourth generation of QIAGEN’s market-leading IGRA technology, is the only IGRA endorsed by the panel physicians group. The physician group also noted that “IGRAs have notable advantages over the TST, including higher accuracy especially in BCG-vaccinated persons, a single visit to obtain a result, and quantitative electronic laboratory-reported results that are confidential and with little to no subjectivity.” Many non-U.S.-born persons have been BCG-vaccinated, particularly individuals from countries with a high prevalence of TB.

Posted in Estero/world news, Medicina/Medicine/Health/Science | Contrassegnato da tag: , , | Leave a Comment »

Clean Your Hands: promote infection prevention!

Posted by fidest press agency su sabato, 21 ottobre 2017

manoBerlin. It is 22 days until World Antibiotic Awareness Week (WAAW) which takes place on 13-19 November 2017. A wide range of resources have already been launched to help everyone take part in the campaign.
You can subscribe to ‘handle antibiotics with care’ updates, and more resources for use on social media will be launched in the coming weeks ( It is clear that the world is finally starting to come together on this issue and a recent global meeting in Berlin demonstrated the latest political, academic and operational commitment.
Working together with a range of experts, the WHO IPC global unit has developed a new infographic on the subject. It specifically highlights the role of IPC in preventing antibiotic resistance in health care and the emergence of antimicrobial resistance (AMR). Once launched, please use the infographic to actively promote IPC as one of the solutions to the global AMR burden.
During WAAW, new WHO Guidelines for Carbapenem-resistant Enterobacteriaceae (CRE) and Carbapenemase-producing (CP) Pseudomonas aeruginosa and Acinetobacter baumannii will also be issued on the WHO web pages. A presentation on these new guidelines will be given by Professor Lindsay Grayson (Austin Health and University of Melbourne, Australia) on 13 November 2017 through Webber Training:, in the Lancet Global Health, there will be an article on priorities for IPC, including in relation to AMR. This publication has been authored by WHO staff, US Centers for Disease Control and Prevention (CDC) staff and other leading global health experts. It has been informed by the organizations participating in WHO’s Global Infection Prevention and Control Network (GIPCN), making this publication a leading paper in shaping the future of IPC around the world.European Antibiotic Awareness Week supporting WAAW – For the first time, the European Centres for Diseases Control (ECDC) and the WHO Regional Office for Europe are making a joint media toolkit available with the aim of providing materials to assist in local activities. A summary of latest data on antibiotic resistance in the European Union (EARS-Net) will also be released on 15 November. (

Posted in Estero/world news, Medicina/Medicine/Health/Science | Contrassegnato da tag: , , , | Leave a Comment »

Global Urinary Tract Infection Treatment Market

Posted by fidest press agency su martedì, 22 agosto 2017

Prostata urinary_bladderThe report, Global Urinary Tract Infection Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.The latest trend gaining momentum in the market is growing awareness of controlled usage of antibiotics. Antibiotic resistance is one of the major problem being faced by the medical world today. Antibiotic resistance can be defined as a term when a microorganism changes itself and remains no longer sensitive to that particular antibiotic. In this condition, the antibiotic is no longer capable of killing or inhibiting the growth of the bacteria.According to the report, one of the major drivers for this market is the relation of UTI with several other factors leading to rising incidence rate of UTI. Interconnection of UTI with other healthcare conditions and changing lifestyle habits have led to the rising incidence of the disease. This, in turn, is expected to rise the demand for the treatment facilities for the UTI. The disease is more common in women as compared with men. Around 50% of the women globally have chances of developing UTI at least once in their lifetime. This accounts for a large population and demands huge attention. Apart from gender, many other factors such as obesity and diabetes contribute to the rising incidence of UTI.

Posted in Medicina/Medicine/Health/Science | Contrassegnato da tag: , , | Leave a Comment »

WHO issuing updated guidelines for treatment of hepatitis C infection

Posted by fidest press agency su martedì, 26 aprile 2016

Hepatitis program1Hepatitis programBarcelona, Spain, In view of the continued rapid progress in the development of new treatments for hepatitis C infection, the World Health Organization (WHO) is issuing updated treatment guidelines. The guidelines promote the transition to newer, more effective medicines that have the potential to cure most persons living with hepatitis C infection. WHO issued its first-ever recommendations on the treatment of hepatitis C virus (HCV) in 2014. Since then, several new medicines have been introduced and marketed. These medicines, called direct-acting antivirals (DAAs), are more effective and easier to use than established treatment regimens. Furthermore, they have been included in WHO’s Model List of Essential Medicines. Treatment with DAAs is short in duration (8–12 weeks), easy to take (as few as 1 pill per day), has few side effects, and results in a cure for more than 90% of people treated. This is a vast improvement from older treatments, which cured less than half of the people treated, required weekly interferon injections for up to 12 months, and often resulted in severe, sometimes fatal, side effects.The new guidelines also provide guidance on which specific regimens should be used (called “preferred regimens”) based on a patient’s clinical history as well as the genotype of HCV (there are 6 genotypes). These preferred regimens simplify treatment decisions by recommending only 3 treatment epatite programregimens for patients without cirrhosis and an additional 2 for patients with cirrhosis.The updated guidelines are intended to promote the scale-up of HCV treatment, particularly in low- and middle-income countries where few people currently have access to hepatitis treatment, despite also being where most people with HCV live. WHO recognizes that implementation of the recommendations may not be immediate, because the treatments can be expensive and the medicines are not yet approved in many countries.The price of DAAs varies dramatically. The cost to treat a single patient in some high-income countries can exceed US$100 000. However, following the introduction of generic versions of DAAs, the price in other countries, such as India, is less than US$ 500 to treat a single patient.Approximately 130–150 million people are estimated to be infected with HCV. Each year, an estimated 700 000 people die from HCV-related complications including fatty liver (cirrhosis), cancer (hepatocellular carcinoma) and liver failure. Unfortunately, many people with HCV only learn about their infection when they develop symptoms from cirrhosis or liver cancer. Because the prices are rapidly dropping, and because the medicines are easy to use, they have the potential to dramatically reduce the number of deaths due to hepatitis C infection. (fonte: World Health Organization – Who

Posted in Cronaca/News, Estero/world news, Medicina/Medicine/Health/Science | Contrassegnato da tag: , , , | Leave a Comment »

New Call for IPC specialists to be deployed to Guinea, Liberia and Sierra Leone

Posted by fidest press agency su martedì, 9 giugno 2015

virus-ebolaDespite of many improvements and the end of the outbreak in Liberia, the Ebola outbreak counting 27 173 cases and 11 149 deaths so far, is not yet over in Guinea and Sierra Leone. Strengthening and implementing infection prevention and control (IPC) measures and best practices have been among the most important actions to contain and eliminate transmission of Ebola both at the community and the healthcare setting levels. IPC capacity building is also one of the highest priorities in the governmental plans for urgent essential health services restoration and health systems recovery.The IPC programme in the WHO Department of Service Delivery and Safety is continuing to provide technical support to countries in the efforts to get to zero Ebola cases in Guinea and Sierra Leone and to build strong and resilient IPC infrastructures, national programmes and expertise in the context of health system recovery in West African countries.The technical support and generous time dedication received by international IPC specialists who accepted to be deployed to the affected countries so far have been CRUCIAL to bring real IPC expertise in the context of the WHO Ebola response and to contribute to contain the outbreak. First of all, I would like to take this opportunity to express my deep gratitude to all those among you who served as IPC international force of WHO consultants over the last months.The activities described above still require strong technical support. As trusted members of our Save Lives: Clean Your Hands network, we are reaching out to you once again to seek your availability to be deployed in West Africa as IPC specialists in the next six months.We are currently recruiting English- or French-speaking IPC qualified medical and nursing staff. We are also interested in professionals with skills in project and data management. For these deployments, we offer WHO Consultant contracts for a period ranging from 2 to a maximum of 6 months.The work will mainly take place at national or district level. In collaboration with the Ministry of Health and partners, and under the supervision of the WHO Country Representative, the WHO National Lead for IPC and other WHO leaders as appropriate, the incumbent will perform the following activities:
1. In coordination with the Ebola Outbreak Response Team (where appropriate) and the National IPC lead, manage IPC priorities and activities in line with WHO IPC guidelines within the overall outbreak response and/or in the context of national plans for health systems recovery.
2. Assess IPC capacities and practices in hospitals and health-care facilities throughout the country, in particular in the areas still affected by the outbreak.
3. Review and improve IPC measures implemented in Ebola facilities, and advise on best approaches for the prevention of healthcare-associated infections in health-care settings.
4. Review training needs for country capacity building, and based on this assessment provide technical support for training in IPC for staff at national, district and facility level as needed.
5. Report to the Ministry of Health and the WHO country office on findings and activities, and advise on effective and feasible IPC activities with regard to getting to zero cases, decommissioning of Ebola facilities, and focusing on recovery of health care services.
6. Provide guidance and technical input to develop IPC policies, tools, training materials, and to identify resources and equipment needed at national, provincial and district level in order to ensure adequate prevention and preparedness for response.
7. Support the Ministry of Health in monitoring, evaluating and documenting IPC activities linked to outbreak response, to decommissioning of Ebola facilities and to health-systems recovery.

Posted in Estero/world news, Spazio aperto/open space | Contrassegnato da tag: , , , | Leave a Comment »

Caritas statement on Pope and HIV and AIDS

Posted by fidest press agency su lunedì, 22 novembre 2010

Caritas Internationaliswelcomes the Pope’s reported comments on the importance of responding to theHIV pandemic. They are an affirmation of the importance of pastoral sensitivityand compassion in HIV and AIDS prevention. The comments are reported inthe book “The Pope, the Church and the Signs of the Times” due to be publishedon November 23. In the book, the Pope isquoted as saying that for some individuals – for instance a male prostitute –the use of a condom to prevent HIV infection can be a first step towardsassuming moral responsibility and adopting a more human way of livingsexuality. He goes on to say that whilecondoms may reduce the risk of infection, the Church does not regard them as areal or moral solution. Caritas Internationalis worksin the prevention of HIV infection and in the treatment and care of thoseliving with HIV and AIDS. Caritas Internationalis SecretaryGeneral, Lesley-Anne Knight, said: “The Pope’s reported comments in this bookillustrate the importance of compassion and sensitivity in dealing with thecomplexities of HIV/AIDS prevention. Caritas delivers its HIV/AIDS programmesin line with Church Teaching and we will consider, in close consultation withthe Holy See, whether there are implications for our work in these reportedcomments of Pope Benedict.” Caritas Internationalis isthe confederation of 165 national Catholic aid agencies. Its members provideHIV programming in more than 100 countries.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »